Advertisement

Loading...

VIVO Cannabis Inc.

VIVO.TOTSX
Healthcare
Drug Manufacturers - Specialty & Generic
$0.03
$0.00(0.00%)
Canadian Market opens in 15h 2m

VIVO Cannabis Inc. Fundamental Analysis

VIVO Cannabis Inc. (VIVO.TO) shows weak financial fundamentals with a PE ratio of -0.19, profit margin of -1.91%, and ROE of -78.09%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position26.47%
PEG Ratio-0.00
Current Ratio3.15

Areas of Concern

ROE-78.09%
Operating Margin-15.36%
We analyze VIVO.TO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -239.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-239.9/100

We analyze VIVO.TO's fundamental strength across five key dimensions:

Efficiency Score

Weak

VIVO.TO struggles to generate sufficient returns from assets.

ROA > 10%
-1.07%

Valuation Score

Excellent

VIVO.TO trades at attractive valuation levels.

PE < 25
-0.19
PEG Ratio < 2
-0.00

Growth Score

Weak

VIVO.TO faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

VIVO.TO maintains a strong and stable balance sheet.

Debt/Equity < 1
0.09
Current Ratio > 1
3.15

Profitability Score

Weak

VIVO.TO struggles to sustain strong margins.

ROE > 15%
-7808.54%
Net Margin ≥ 15%
-1.91%
Positive Free Cash Flow
No

Key Financial Metrics

Is VIVO.TO Expensive or Cheap?

P/E Ratio

VIVO.TO trades at -0.19 times earnings. This suggests potential undervaluation.

-0.19

PEG Ratio

When adjusting for growth, VIVO.TO's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values VIVO Cannabis Inc. at 0.24 times its book value. This may indicate undervaluation.

0.24

EV/EBITDA

Enterprise value stands at 4.31 times EBITDA. This is generally considered low.

4.31

How Well Does VIVO.TO Make Money?

Net Profit Margin

For every $100 in sales, VIVO Cannabis Inc. keeps $-1.91 as profit after all expenses.

-1.91%

Operating Margin

Core operations generate -15.36 in profit for every $100 in revenue, before interest and taxes.

-15.36%

ROE

Management delivers $-78.09 in profit for every $100 of shareholder equity.

-78.09%

ROA

VIVO Cannabis Inc. generates $-1.07 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.07%

Following the Money - Real Cash Generation

Operating Cash Flow

VIVO Cannabis Inc. generates limited operating cash flow of $-6.19M, signaling weaker underlying cash strength.

$-6.19M

Free Cash Flow

VIVO Cannabis Inc. generates weak or negative free cash flow of $-6.72M, restricting financial flexibility.

$-6.72M

FCF Per Share

Each share generates $-0.02 in free cash annually.

$-0.02

FCF Yield

VIVO.TO converts -72.52% of its market value into free cash.

-72.52%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.19

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.24

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.36

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.09

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.15

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.78

vs 25 benchmark

ROA

Return on assets percentage

-1.07

vs 25 benchmark

ROCE

Return on capital employed

-0.10

vs 25 benchmark

How VIVO.TO Stacks Against Its Sector Peers

MetricVIVO.TO ValueSector AveragePerformance
P/E Ratio-0.1928.31 Better (Cheaper)
ROE-78.09%699.00% Weak
Net Margin-190.52%-131318.00% (disorted) Weak
Debt/Equity0.090.34 Strong (Low Leverage)
Current Ratio3.152775.16 Strong Liquidity
ROA-106.59%-14513.00% (disorted) Weak

VIVO.TO outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews VIVO Cannabis Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ